Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course

RE Harris; M Aloi; Lissy de Ridder; NM Croft; S Koletzko; A Levine; D Turner; G Veereman; M Neyt; L Bigot; FM Ruemmele

doi:10.1136/bmjopen-2019-034892

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course

RE Harris, M Aloi, Lissy de Ridder, NM Croft, S Koletzko, A Levine, D Turner, G Veereman, M Neyt, L Bigot, FM Ruemmele

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Original language	English
Article number	e034892
Journal	BMJ Open
Volume	10
DOIs	https://doi.org/10.1136/bmjopen-2019-034892
Publication status	Published - 2020

Research programs

EMC MM-04-54-07

Access to Document

10.1136/bmjopen-2019-034892

Cite this

Harris, RE., Aloi, M., de Ridder, L., Croft, NM., Koletzko, S., Levine, A., Turner, D., Veereman, G., Neyt, M., Bigot, L., & Ruemmele, FM. (2020). Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course. BMJ Open, 10, Article e034892. https://doi.org/10.1136/bmjopen-2019-034892

@article{46308f79c2dd4db1aa62fd98e24353e2,

title = "Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course",

author = "RE Harris and M Aloi and {de Ridder}, Lissy and NM Croft and S Koletzko and A Levine and D Turner and G Veereman and M Neyt and L Bigot and FM Ruemmele",

year = "2020",

doi = "10.1136/bmjopen-2019-034892",

language = "English",

volume = "10",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

}

Harris, RE, Aloi, M, de Ridder, L, Croft, NM, Koletzko, S, Levine, A, Turner, D, Veereman, G, Neyt, M, Bigot, L & Ruemmele, FM 2020, 'Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course', BMJ Open, vol. 10, e034892. https://doi.org/10.1136/bmjopen-2019-034892

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course. / Harris, RE; Aloi, M; de Ridder, Lissy et al.
In: BMJ Open, Vol. 10, e034892, 2020.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathrioprine of adalimumab for maintaining remission in patients at low high risk for aggressive disease course

AU - Harris, RE

AU - Aloi, M

AU - de Ridder, Lissy

AU - Croft, NM

AU - Koletzko, S

AU - Levine, A

AU - Turner, D

AU - Veereman, G

AU - Neyt, M

AU - Bigot, L

AU - Ruemmele, FM

PY - 2020

Y1 - 2020

U2 - 10.1136/bmjopen-2019-034892

DO - 10.1136/bmjopen-2019-034892

M3 - Article

C2 - 32611737

SN - 2044-6055

VL - 10

JO - BMJ Open

JF - BMJ Open

M1 - e034892

ER -